Phase II preradiation R115777 (tipifarnib) in newly diagnosed GBM with residual enhancing disease

Robert Lustig, Tom Mikkelsen, Glenn Lesser, Stuart Grossman, Xiaobu Ye, Serena Desideri, Joy Fisher, John Wright

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II preradiation R115777 (tipifarnib) in newly diagnosed GBM with residual enhancing disease'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Agricultural and Biological Sciences